137 related articles for article (PubMed ID: 10505770)
1. Biologic therapy for lymphoma.
Bendandi M; Longo DL
Curr Opin Oncol; 1999 Sep; 11(5):343-50. PubMed ID: 10505770
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies in the treatment of lymphoma].
Mounier N; Gisselbrecht C
Rev Prat; 2002 May; 52(9):982-5. PubMed ID: 12063765
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.
Gadri Z; Kukulansky T; Bar-Or E; Haimovich J; Hollander N
J Immunother; 2009 May; 32(4):333-40. PubMed ID: 19342972
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for lymphomas.
Timmerman JM
Int J Hematol; 2003 Jun; 77(5):444-55. PubMed ID: 12841382
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy in lymphoid malignancies.
Hainsworth JD
Oncologist; 2000; 5(5):376-84. PubMed ID: 11040273
[TBL] [Abstract][Full Text] [Related]
7. Advances in follicular lymphoma.
Archuleta TD; Armitage JO
Semin Oncol; 2004 Apr; 31(2 Suppl 4):66-71. PubMed ID: 15124137
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma: today's treatments and tomorrow's targets.
Aurora V; Winter JN
Expert Opin Pharmacother; 2006 Jul; 7(10):1273-90. PubMed ID: 16805715
[TBL] [Abstract][Full Text] [Related]
9. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
10. Antibody therapy of lymphoma.
Illidge TM; Bayne MC
Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
[TBL] [Abstract][Full Text] [Related]
11. Unique toxicities and resistance mechanisms associated with monoclonal antibody therapy.
Friedberg JW
Hematology Am Soc Hematol Educ Program; 2005; ():329-34. PubMed ID: 16304399
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugates.
Leonard JP
Hematology Am Soc Hematol Educ Program; 2005; ():335-9. PubMed ID: 16304400
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy: on the edge between experimental and clinical oncology.
Fagnoni FF; Robustelli della Cuna G
J Chemother; 2001 Feb; 13(1):15-23. PubMed ID: 11233795
[TBL] [Abstract][Full Text] [Related]
14. [Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas].
Trnený M; Klener P
Cas Lek Cesk; 2007; 146(7):578-85. PubMed ID: 17722844
[TBL] [Abstract][Full Text] [Related]
15. Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects.
Maloney DG
Hematology Am Soc Hematol Educ Program; 2007; ():226-32. PubMed ID: 18024634
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Maloney DG
J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
[TBL] [Abstract][Full Text] [Related]
17. A review of monoclonal antibody therapies in lymphoma.
Teo EC; Chew Y; Phipps C
Crit Rev Oncol Hematol; 2016 Jan; 97():72-84. PubMed ID: 26318093
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for non-Hodgkin's lymphoma.
Longo DL
Curr Opin Oncol; 1996 Sep; 8(5):353-9. PubMed ID: 8914801
[TBL] [Abstract][Full Text] [Related]
19. [Proteins in haematology].
Clarenbach RE; Mey U
Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
[TBL] [Abstract][Full Text] [Related]
20. Biologic agents and approaches in the management of patients with lymphoma. A critical appraisal.
Longo DL
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1067-87. PubMed ID: 1718939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
